Genomic Insight into Mechanisms of Reversion of Antibiotic Resistance in Multidrug Resistant Mycobacterium tuberculosis Induced by a Nanomolecular Iodine-Containing Complex FS-1
出版年份 2017 全文链接
标题
Genomic Insight into Mechanisms of Reversion of Antibiotic Resistance in Multidrug Resistant Mycobacterium tuberculosis Induced by a Nanomolecular Iodine-Containing Complex FS-1
作者
关键词
-
出版物
Frontiers in Cellular and Infection Microbiology
Volume 7, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2017-05-08
DOI
10.3389/fcimb.2017.00151
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Acute and subchronic toxicity studies of the original drug FS-1
- (2016) Assem Kalykova et al. ACTA VETERINARIA BRNO
- Delamanid and Bedaquiline Resistance inMycobacterium tuberculosisAncestral Beijing Genotype Causing Extensively Drug-Resistant Tuberculosis in a Tibetan Refugee
- (2016) Harald Hoffmann et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- High Persister Mutants in Mycobacterium tuberculosis
- (2016) Heather L. Torrey et al. PLoS One
- Experimental Evolution of Mycobacterium tuberculosis in Human Macrophages Results in Low-Frequency Mutations Not Associated with Selective Advantage
- (2016) Valentina Guerrini et al. PLoS One
- Phylogeny to function: PE/PPE protein evolution and impact onMycobacterium tuberculosispathogenicity
- (2015) S. Fishbein et al. MOLECULAR MICROBIOLOGY
- Delamanid for Extensively Drug-Resistant Tuberculosis
- (2015) Rajesh Gupta et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multidrug evolutionary strategies to reverse antibiotic resistance
- (2015) M. Baym et al. SCIENCE
- Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study
- (2014) Elize Pietersen et al. LANCET
- Role of the Mmr Efflux Pump in Drug Resistance in Mycobacterium tuberculosis
- (2012) L. Rodrigues et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Both Phthiocerol Dimycocerosates and Phenolic Glycolipids Are Required for Virulence of Mycobacterium marinum
- (2012) Jia Yu et al. INFECTION AND IMMUNITY
- The crisis of no new antibiotics—what is the way forward?
- (2011) Laura JV Piddock LANCET INFECTIOUS DISEASES
- The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis
- (2009) F. Luciani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tuberculosis Drug Resistance Mutation Database
- (2009) Andreas Sandgren et al. PLOS MEDICINE
- New Drugs against Tuberculosis: Problems, Progress, and Evaluation of Agents in Clinical Development
- (2008) J. van den Boogaard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug-resistant tuberculosis
- (2008) Ellen M Zager et al. BMC INFECTIOUS DISEASES
- Anti-tuberculosis medication side-effects constitute major factor for poor adherence to tuberculosis treatment
- (2008) Niyi Awofeso BULLETIN OF THE WORLD HEALTH ORGANIZATION
- The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America
- (2007) B. Spellberg et al. CLINICAL INFECTIOUS DISEASES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started